CliffBio
small molecule

ACTRON

KETOPROFEN

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameACTRON
Active ingredientKETOPROFEN
Strength12.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1995
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.